Objectives: The present study aimed to examine the cytogenetic and genetic mutation features of acutemyeloid leukemia (AML) in elderly Chinese patients. Methods: A retrospective analysis of cytogenetics andgenetic mutations was performed in 113 cases (age range 50-82 years) with de novo AML. Results: The mostfrequent cytogenetic abnormality was t (15;17) (q22;q21), detected in 10.0% (n = 9) of successfully analyzedcases, followed by t (8;21) (q22;q22) in 8.89% (n = 8), and complex karyotypes in 5.56% (n = 5). Those withcomplex karyotypes included 4 cases (4.44%) of monosomal karyotypes. The frequencies of NPM1, FLT3-ITD,c-kit, and CEBPA mutations were 27.4% (31/113), 14.5% (16/110), 5.88% (6/102), and 23.3% (7/30), respectively.The complete remission rates of patients in low, intermediate, and high risk groups were 37.5%, 48.6%, and33.3%, respectively (χ2 = 0.704, P = 0.703) based on risk stratification. Conclusion: Cytogenetics and geneticmutations alone may not be sufficient to evaluate the prognoses of elderly AML patients. The search for a novelmodel that would enable a more comprehensive evaluation of this population is therefore imperative.
(2014). Cytogenetic and Genetic Mutation Features of de novo Acute Myeloid Leukemia in Elderly Chinese Patients. Asian Pacific Journal of Cancer Prevention, 15(2), 895-898.
MLA
. "Cytogenetic and Genetic Mutation Features of de novo Acute Myeloid Leukemia in Elderly Chinese Patients". Asian Pacific Journal of Cancer Prevention, 15, 2, 2014, 895-898.
HARVARD
(2014). 'Cytogenetic and Genetic Mutation Features of de novo Acute Myeloid Leukemia in Elderly Chinese Patients', Asian Pacific Journal of Cancer Prevention, 15(2), pp. 895-898.
VANCOUVER
Cytogenetic and Genetic Mutation Features of de novo Acute Myeloid Leukemia in Elderly Chinese Patients. Asian Pacific Journal of Cancer Prevention, 2014; 15(2): 895-898.